Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$36.50
-0.31-0.84%
At close: -
$36.50
0.000.00%
After Hours: 4:39 PM EDT
Comments
Loading...
Exelixis Analyst Ratings and Price Targets | NASDAQ:EXEL | Benzinga
Exelixis Inc has a consensus price target of $34.29 based on the ratings of 25 analysts. The high is $45 issued by Citigroup on February 12, 2025. The low is $18 issued by SVB Leerink on August 8, 2023. The 3 most-recent analyst ratings were released by JMP Securities, HC Wainwright & Co., and RBC Capital on April 17, 2025, March 27, 2025, and March 13, 2025, respectively. With an average price target of $40.33 between JMP Securities, HC Wainwright & Co., and RBC Capital, there's an implied 10.50% upside for Exelixis Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
HC Wainwright & Co.
RBC Capital
Wells Fargo
Barclays
1calculated from analyst ratings
Analyst Ratings for Exelixis
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/17/2025 | Buy Now | 12.33% | JMP Securities | Silvan Tuerkcan46% | $41 → $41 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/27/2025 | Buy Now | 9.59% | HC Wainwright & Co. | Robert Burns42% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 03/13/2025 | Buy Now | 9.59% | RBC Capital | Gregory Renza49% | $38 → $40 | Maintains | Outperform | Get Alert |
| 02/24/2025 | Buy Now | -1.37% | Wells Fargo | Derek Archila65% | $36 → $36 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/13/2025 | Buy Now | -20.55% | Barclays | Peter Lawson41% | $25 → $29 | Maintains | Equal-Weight | Get Alert |
| 02/13/2025 | Buy Now | 9.59% | HC Wainwright & Co. | Robert Burns42% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 02/12/2025 | Buy Now | 23.29% | Citigroup | David Lebowitz55% | $38 → $45 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 15.07% | Guggenheim | Michael Schmidt54% | $42 → $42 | Reiterates | Buy → Buy | Get Alert |
| 02/12/2025 | Buy Now | -20.55% | Stephens & Co. | Sudan Loganathan30% | $29 → $29 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 02/12/2025 | Buy Now | -1.37% | Stifel | Stephen Willey50% | $30 → $36 | Maintains | Hold | Get Alert |
| 02/12/2025 | Buy Now | 4.11% | Piper Sandler | Joseph Catanzaro32% | $37 → $38 | Maintains | Overweight | Get Alert |
| 01/28/2025 | Buy Now | -6.85% | UBS | Ashwani Verma45% | $30 → $34 | Maintains | Neutral | Get Alert |
| 01/27/2025 | Buy Now | 12.33% | JMP Securities | Silvan Tuerkcan46% | $41 → $41 | Maintains | Market Outperform | Get Alert |
| 01/27/2025 | Buy Now | 17.81% | Truist Securities | Asthika Goonewardene41% | $42 → $43 | Maintains | Buy | Get Alert |
| 01/27/2025 | Buy Now | -20.55% | Stephens & Co. | Sudan Loganathan30% | $29 → $29 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 01/27/2025 | Buy Now | 9.59% | HC Wainwright & Co. | Robert Burns42% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
| 01/27/2025 | Buy Now | 9.59% | Morgan Stanley | Jefferson Harralson60% | $30 → $40 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/24/2025 | Buy Now | -9.59% | Oppenheimer | Jay Olson61% | $41 → $33 | Downgrade | Outperform → Perform | Get Alert |
| 01/23/2025 | Buy Now | 12.33% | JMP Securities | Silvan Tuerkcan46% | $41 → $41 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 01/22/2025 | Buy Now | — | Guggenheim | Michael Schmidt54% | — | Reiterates | Buy → Buy | Get Alert |
| 01/16/2025 | Buy Now | 12.33% | Oppenheimer | Jay Olson61% | $38 → $41 | Maintains | Outperform | Get Alert |
| 01/15/2025 | Buy Now | 15.07% | Truist Securities | Asthika Goonewardene41% | $38 → $42 | Maintains | Buy | Get Alert |
| 01/15/2025 | Buy Now | 12.33% | JMP Securities | Silvan Tuerkcan46% | $34 → $41 | Maintains | Market Outperform | Get Alert |
| 01/13/2025 | Buy Now | 1.37% | Piper Sandler | Joseph Catanzaro32% | $36 → $37 | Maintains | Overweight | Get Alert |
| 01/10/2025 | Buy Now | 9.59% | HC Wainwright & Co. | Robert Burns42% | $29 → $40 | Maintains | Buy | Get Alert |
| 01/07/2025 | Buy Now | 15.07% | Guggenheim | Michael Schmidt54% | $33 → $42 | Maintains | Buy | Get Alert |
| 12/23/2024 | Buy Now | — | Brookline Capital | Leah Rush62% | — | Initiates | → Buy | Get Alert |
| 12/20/2024 | Buy Now | 9.59% | BMO Capital | Etzer Darout45% | $36 → $40 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/17/2024 | Buy Now | 6.85% | B of A Securities | Jason Gerberry59% | $35 → $39 | Downgrade | Buy → Neutral | Get Alert |
| 10/30/2024 | Buy Now | -9.59% | Guggenheim | Michael Schmidt54% | $32 → $33 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -20.55% | Stephens & Co. | Sudan Loganathan30% | $23 → $29 | Maintains | Equal-Weight | Get Alert |
| 10/30/2024 | Buy Now | -1.37% | Piper Sandler | Joseph Catanzaro32% | $33 → $36 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | -6.85% | RBC Capital | Gregory Renza49% | $34 → $34 | Reiterates | Outperform → Outperform | Get Alert |
| 10/30/2024 | Buy Now | 4.11% | Truist Securities | Asthika Goonewardene41% | $33 → $38 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -1.37% | Wells Fargo | Derek Archila65% | $32 → $36 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | -1.37% | BMO Capital | Etzer Darout45% | $29 → $36 | Maintains | Outperform | Get Alert |
| 10/21/2024 | Buy Now | -6.85% | TD Cowen | Yaron Werber37% | $27 → $34 | Maintains | Buy | Get Alert |
| 10/16/2024 | Buy Now | -17.81% | Stifel | Stephen Willey50% | $26 → $30 | Maintains | Hold | Get Alert |
| 10/16/2024 | Buy Now | -6.85% | RBC Capital | Gregory Renza49% | $30 → $34 | Maintains | Outperform | Get Alert |
| 10/16/2024 | Buy Now | -6.85% | JMP Securities | Silvan Tuerkcan46% | $29 → $34 | Maintains | Market Outperform | Get Alert |
| 10/15/2024 | Buy Now | -12.33% | B of A Securities | Jason Gerberry59% | $30 → $32 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | -20.55% | JMP Securities | Silvan Tuerkcan46% | $29 → $29 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/11/2024 | Buy Now | -23.29% | Morgan Stanley | Jefferson Harralson60% | $26 → $28 | Maintains | Equal-Weight | Get Alert |
| 10/04/2024 | Buy Now | -17.81% | RBC Capital | Gregory Renza49% | $27 → $30 | Maintains | Outperform | Get Alert |
| 09/26/2024 | Buy Now | -26.03% | RBC Capital | Gregory Renza49% | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 09/20/2024 | Buy Now | -20.55% | JMP Securities | Silvan Tuerkcan46% | $29 → $29 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/19/2024 | Buy Now | -17.81% | UBS | Ashwani Verma45% | → $30 | Initiates | → Neutral | Get Alert |
| 09/18/2024 | Buy Now | -20.55% | HC Wainwright & Co. | Robert Burns42% | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | -9.59% | Truist Securities | Asthika Goonewardene41% | $32 → $33 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | -20.55% | JMP Securities | Silvan Tuerkcan46% | $27 → $29 | Maintains | Market Outperform | Get Alert |
| 08/07/2024 | Buy Now | -26.03% | RBC Capital | Gregory Renza49% | $27 → $27 | Reiterates | Outperform → Outperform | Get Alert |
| 07/30/2024 | Buy Now | -20.55% | Oppenheimer | Jay Olson61% | $29 → $29 | Maintains | Outperform | Get Alert |
| 05/14/2024 | Buy Now | -36.99% | Stephens & Co. | Sudan Loganathan30% | → $23 | Initiates | → Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | -23.29% | HC Wainwright & Co. | Robert Burns42% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | -26.03% | TD Cowen | Yaron Werber37% | $25 → $27 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | -31.51% | Barclays | Peter Lawson41% | $25 → $25 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | -26.03% | JMP Securities | Silvan Tuerkcan46% | $27 → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/07/2024 | Buy Now | -23.29% | RBC Capital | Gregory Renza49% | $26 → $28 | Maintains | Outperform | Get Alert |
| 02/02/2024 | Buy Now | -31.51% | Stifel | Stephen Willey50% | $23 → $25 | Maintains | Hold | Get Alert |
| 01/30/2024 | Buy Now | -31.51% | Barclays | Peter Lawson41% | $24 → $25 | Maintains | Overweight | Get Alert |
| 12/19/2023 | Buy Now | -26.03% | BTIG | Kaveri Pohlman26% | → $27 | Initiates | → Buy | Get Alert |
| 12/15/2023 | Buy Now | -15.07% | Citigroup | David Lebowitz55% | → $31 | Initiates | → Buy | Get Alert |
| 12/14/2023 | Buy Now | -26.03% | JMP Securities | Silvan Tuerkcan46% | $27 → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/13/2023 | Buy Now | -28.77% | RBC Capital | Gregory Renza49% | $26 → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2023 | Buy Now | -26.03% | JMP Securities | Silvan Tuerkcan46% | → $27 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/02/2023 | Buy Now | -36.99% | Morgan Stanley | Jefferson Harralson60% | $22 → $23 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | Buy Now | -17.81% | Guggenheim | Michael Schmidt54% | → $30 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | Buy Now | -23.29% | HC Wainwright & Co. | Robert Burns42% | → $28 | Initiates | → Buy | Get Alert |
| 09/25/2023 | Buy Now | -17.81% | Guggenheim | Michael Schmidt54% | $27 → $30 | Maintains | Buy | Get Alert |
| 09/13/2023 | Buy Now | -36.99% | Stifel | Stephen Willey50% | → $23 | Reiterates | Hold → Hold | Get Alert |
| 09/13/2023 | Buy Now | -12.33% | Truist Securities | Asthika Goonewardene41% | → $32 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | Buy Now | -20.55% | Oppenheimer | Jay Olson61% | $25 → $29 | Maintains | Outperform | Get Alert |
| 08/22/2023 | Buy Now | -26.03% | JMP Securities | Silvan Tuerkcan46% | $24 → $27 | Maintains | Outperform | Get Alert |
| 08/08/2023 | Buy Now | -50.68% | SVB Leerink | Christopher Liu51% | → $18 | Initiates | → Market Perform | Get Alert |
| 08/03/2023 | Buy Now | -34.25% | Barclays | Peter Lawson41% | $25 → $24 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | -36.99% | Stifel | Stephen Willey50% | $21 → $23 | Maintains | Hold | Get Alert |
| 08/02/2023 | Buy Now | -39.73% | Morgan Stanley | Jefferson Harralson60% | $21 → $22 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | -34.25% | JMP Securities | Silvan Tuerkcan46% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/31/2023 | Buy Now | -31.51% | Oppenheimer | Jay Olson61% | → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 07/19/2023 | Buy Now | -34.25% | JMP Securities | Silvan Tuerkcan46% | → $24 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/11/2023 | Buy Now | -42.47% | Morgan Stanley | Jefferson Harralson60% | → $21 | Reinstates | → Equal-Weight | Get Alert |
| 05/10/2023 | Buy Now | -34.25% | JMP Securities | Silvan Tuerkcan46% | → $24 | Reiterates | → Market Outperform | Get Alert |
| 05/10/2023 | Buy Now | -23.29% | Piper Sandler | Joseph Catanzaro32% | → $28 | Assumes | → Overweight | Get Alert |
| 04/28/2023 | Buy Now | -34.25% | EF Hutton | Michael King42% | → $24 | Reiterates | → Buy | Get Alert |
| 04/12/2023 | Buy Now | -42.47% | Morgan Stanley | Jefferson Harralson60% | $22 → $21 | Maintains | Equal-Weight | Get Alert |
| 03/20/2023 | Buy Now | -34.25% | EF Hutton | Michael King42% | → $24 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | -36.99% | Wells Fargo | Derek Archila65% | → $23 | Initiates | → Overweight | Get Alert |
| 03/03/2023 | Buy Now | -34.25% | EF Hutton | Michael King42% | → $24 | Reiterates | → Buy | Get Alert |
| 02/14/2023 | Buy Now | -34.25% | EF Hutton | Michael King42% | → $24 | Maintains | Buy | Get Alert |
| 02/08/2023 | Buy Now | -12.33% | Piper Sandler | Alexander Goldfarb56% | → $32 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | -34.25% | EF Hutton | Michael King42% | → $24 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | Buy Now | -20.55% | Credit Suisse | Tiago Fauth43% | → $29 | Initiates | → Outperform | Get Alert |
| 01/19/2023 | Buy Now | -34.25% | JMP Securities | Silvan Tuerkcan46% | $25 → $24 | Maintains | Market Outperform | Get Alert |
| 01/11/2023 | Buy Now | -34.25% | EF Hutton | Michael King42% | $28 → $24 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | -31.51% | JMP Securities | Silvan Tuerkcan46% | $26 → $25 | Maintains | Market Outperform | Get Alert |
| 11/02/2022 | Buy Now | -20.55% | RBC Capital | Gregory Renza49% | $31 → $29 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | -39.73% | Morgan Stanley | Jeffrey Hung50% | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 11/01/2022 | Buy Now | -23.29% | EF Hutton | Michael King42% | → $28 | Initiates | → Buy | Get Alert |
| 10/18/2022 | Buy Now | -28.77% | JMP Securities | Silvan Tuerkcan46% | → $26 | Initiates | → Market Outperform | Get Alert |
| 07/26/2022 | Buy Now | -12.33% | Piper Sandler | Do Kim54% | $30 → $32 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Exelixis (EXEL) stock?
The latest price target for Exelixis (NASDAQ:EXEL) was reported by JMP Securities on April 17, 2025. The analyst firm set a price target for $41.00 expecting EXEL to rise to within 12 months (a possible 12.33% upside). 53 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exelixis (EXEL)?
The latest analyst rating for Exelixis (NASDAQ:EXEL) was provided by JMP Securities, and Exelixis reiterated their market outperform rating.
When was the last upgrade for Exelixis (EXEL)?
The last upgrade for Exelixis Inc happened on January 27, 2025 when Morgan Stanley raised their price target to $40. Morgan Stanley previously had an equal-weight for Exelixis Inc.
When was the last downgrade for Exelixis (EXEL)?
The last downgrade for Exelixis Inc happened on February 24, 2025 when Wells Fargo changed their price target from $36 to $36 for Exelixis Inc.
When is the next analyst rating going to be posted or updated for Exelixis (EXEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on April 17, 2025 so you should expect the next rating to be made available sometime around April 17, 2026.
Is the Analyst Rating Exelixis (EXEL) correct?
While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a reiterated with a price target of $41.00 to $41.00. The current price Exelixis (EXEL) is trading at is $36.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
